2021

Traditionally, early-career scientists and those with more novel approaches to their research face considerable difficulty securing funding for their work. This is partly due to the higher-risk nature of their work, while both established scientists and those pursuing proven methods of study are considered less risky to fund. New Vision Research alters the current landscape of funding by intentionally connecting and supporting early-career researchers with innovative ideas through CCAD.

A Way Forward is a four-part series dedicated to sharing these challenges with the CCAD community, along with ways to help address them and contribute to their resolution.

We believe diversity in ideas leads to better medical research, and to achieve this, it is important to identify and address individual, community and institutional challenges scientists face that hold us back as a community. The first piece is written by PhD student Melise Edwards. To read her article click on the button below.

I am excited to share a brief update on my research since attending the Charleston Conferences on Alzheimer’s Disease (CCAD) in 2014. It is hard to capture the entire roller coaster ride of starting a research lab, so I will share a few highlights. Currently, I am an Associate Professor with appointments in the Department of Pharmacology & Chemical Biology and Neurology in the School of Medicine at Emory University…

NIH R01 Grant Outcomes of T32 Postdoctoral Participants: Associations with Demographics, Cohort, Degree, and Career Development (K) Awards NIH has published a study that presents data on NIH career development, or K award and R01 equivalent research grant outcomes of participants in the post-doctoral T32 programs.  This program aims to provide select trainees with experience

Meet the Faces of CCAD Click through our yearbook to see where your fellow alumni are now.